ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA – Get Free Report) shares rose 3.8% during mid-day trading on Thursday . The stock traded as high as $0.2727 and last traded at $0.27. Approximately 119,589 shares were traded during trading, an increase of 23% from the average daily volume of 97,228 shares. The stock had previously closed at $0.26.
ZyVersa Therapeutics Trading Up 3.8%
The company’s 50 day simple moving average is $0.20 and its 200 day simple moving average is $0.16. The stock has a market capitalization of $2.14 million, a PE ratio of -0.20 and a beta of 0.66.
About ZyVersa Therapeutics
ZyVersa Therapeutics, Inc, a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, IgA neuropathy, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity.
Featured Articles
- Five stocks we like better than ZyVersa Therapeutics
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for ZyVersa Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZyVersa Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
